Factors assessed | Number of studies (SD) | Main findings | Strength of evidence (high, moderate, low, very low) |
---|---|---|---|
Adherence (poor versus good) | 6 (cross-sectional) | Odds ratio: 5.90 (95%CI, 3.50–9.94) | Moderatea |
Adherence (poor versus good) | 4 (cohort studies) | Hazar ratio: 2.46 (95% CI, 1.72–3.51) | High |
CD4 cell count (< 200 versus ≥ 200 cells/mm3) | 3 (cross-sectional) | Odd ratio: 4.82 (95% CI, 2.44–9.52) | Lowb |
CD4 cell count (< 200 versus ≥ 200 cells/mm3) | 4 (cohort studies) | Hazard ratio: 2.98 (95% CI, 2.23–4.0) | Moderatec |
CD4 cell count (< 100 versus ≥ 100 cells/mm3) | 2 (cross-sectional) | Odds ratio: 1.14 (95% CI, 0.52–2.47) | Lowd |